Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LaFleur Minerals Announces MOU with Granada Gold on Milling Assessment (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Verve Therapeutics Inc VERV

Healthcare Biotechnology
Verve Therapeutics, Inc. is a clinical-stage genetic medicines company. The Company is focused on developing a new approach to the care of cardiovascular disease (CVD), transforming treatment from chronic management to single-course gene editing medicines. The Company’s lead programs include VERVE-101, VERVE-102, and VERVE-201, which target genes that have been validated as targets for lowering... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:VERV)

Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for VERVE-102, an Investigational Gene Editing Medicine Designed to Durably Lower Cholesterol After a Single Dose

GlobeNewswire 3 days ago

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire March 3, 2025

Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire February 27, 2025

Lifshitz Law PLLC Announces Investigations of Orthofix Medical Inc. (NASDAQ:OFIX), DexCom, Inc. (NASDAQ:DXCM), Methode Electronics, Inc. (NYSE:MEI), and Verve Therapeutics, Inc. (NASDAQ:VERV).

ACCESS Newswire February 4, 2025

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire February 3, 2025

Kuehn Law Encourages Investors of Verve Therapeutics, Inc. to Contact Law Firm

PR Newswire January 31, 2025

Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference

GlobeNewswire January 29, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Verve Therapeutics, Inc. (VERV) and Encourages Shareholders to Learn More About the Investigation

ACCESS Newswire January 26, 2025

Lifshitz Law PLLC Announces Investigations of Orthofix Medical Inc. (NASDAQ:OFIX), DexCom, Inc. (NASDAQ:DXCM), Methode Electronics, Inc. (NYSE:MEI), and Verve Therapeutics, Inc. (NASDAQ:VERV).

ACCESS Newswire January 24, 2025
View More News ››

Opinion & Analysis (NDAQ:VERV)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:VERV)

(VERV) Technical Data

BREAKING NEWS: $VERV (VERV) Technical Data2025-03-06 01:14:00 ET Stock Traders Daily has produced this trading report using a...
whytestocks - March 6, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeu

News; $VERV Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Stockholders to Inquire about Securities...
whytestocks - January 12, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Verve Th

News; $VERV Bronstein, Gewirtz & Grossman, LLC Is Investigating Verve Therapeutics, Inc. (VERV) And Encourages Investors to...
whytestocks - January 2, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigatio

Just In: $VERV Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Verve Therapeutics, Inc. (VERV...
whytestocks - December 15, 2024

VERV Investors Have Opportunity to Lead Verve Therapeutics,

JUST IN: $VERV VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit Filed by the Schall Law...
whytestocks - September 4, 2024

Verve Therapeutics, Inc. (NASDAQ:VERV): A Promising Genetic

http://beyondspx.com/2024/08/02/verve-therapeutics-inc-nasdaqverv-a-promising-genetic-medicine-company-navigating-challenges/
MikeTester - August 3, 2024
View more Bullboard ››

Patriot Responder Technologies

Patriot Responder Technologies

Patriot Responder, in collaboration with Virginia Commonwealth University (VCU), is addressing a critical gap in public ...
View More »